The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Azacitidine Rowex 25 mg/ml Powder for suspension for injection



Rowex LtdPA0711/297/001

Main Information

Trade NameAzacitidine Rowex 25 mg/ml Powder for suspension for injection
Active SubstancesAzacitidine
Dosage FormPowder for suspension for injection
Licence HolderRowex Ltd
Licence NumberPA0711/297/001

Group Information

ATC CodeL01BC07 azacitidine

Status

License statusAuthorised
Licence Issued12/06/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back